Citichem India Limited - IPO
SMECitichem India Stock Price
Citichem India IPO Details
Citichem India IPO Subscription
Citichem India IPO Application Wise Breakup
Citichem India IPO Dates
- 27 Dec 2024Opening dateOPD
- 31 Dec 2024Closing dateCOD
- 01 Jan 2025Basis of AllotmentBOA
- 02 Jan 2025Initiation of RefundsIOR
- 02 Jan 2025Credit of SharesCOS
- 03 Jan 2025Listing dateLID
Citichem India IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retain Minimum | 1 | 2000 | ₹140,000 |
| Retain Maximum | 1 | 2000 | ₹140,000 |
| HNI Minimum | 2 | 4000 | ₹280,000 |
Citichem India IPO Reservation
Promoter Holding
Documents
Citichem India IPO Valuations
Citichem India Limited Financial Information
| Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
| Assets | 6,851.56 | 6,932.79 | 7,972.53 | 9,142.69 | ||||||||||||||||||||||||||||||||||||
| Revenue | 149.07 | 1,960.58 | 2,094.07 | 8,528 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 19.95 | 111.83 | 36.26 | 23.94 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 745.06 | 725.11 | 613.27 | 577.01 | ||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 245.06 | 225.11 | 113.27 | 77.01 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 108.21 | 108.21 | 109.65 | 110.62 | ||||||||||||||||||||||||||||||||||||
| Amount in ₹ Lakhs | ||||||||||||||||||||||||||||||||||||||||
About Citichem India IPO
Incorporated in 1992, Citichem India Limited is engaged in buying and supplying organic and inorganic chemicals, bulk drugs, and food chemicals to the the pharmaceutical industry.
The company focuses on the direct supply of specialty chemicals, bulk drugs, and intermediate products.
It trades in specialty chemicals and intermediates that have a wide range of applications across industries such as aluminum, steel, textiles, paper, dairy, paints, dyes and intermediates, soap making, pharmaceuticals, food, and adhesives.
The company also supplies food preservatives and chemicals under its brand name, which are then sold through its distribution team, ensuring the safe delivery of bulk supplies.
The company supplies products such as Caustic Soda Flakes, Caustic Soda Lye, Citric Acid Monohydrate, Hydrogen Peroxide, and more.
Business division:
- Specialty Chemicals, Intermediates & Active Pharmaceutical Ingredients (API): The company specializes in indenting, sourcing, make-to-order outsourcing, and supplying specialty chemicals, bulk drugs, and APIs to domestic and international clients in the pharmaceutical, paint, and food industries.
- Food Chemicals: The company handles the repackaging, retail distribution, and marketing of food chemicals.
- Laboratory Chemicals: The company offers a one-stop solution for all types of laboratory chemicals.
As of June 30, 2024, The company has 9 employees.
Competitive Strengths:
- Experienced Promoters and management team
- Scalable Business Model
- Focus on quality and innovation
- Location Advantage
- Cordial Relationships with Suppliers &Customers
- Dedicated after-sales network
Strength Of Citichem India IPO
1. Quality and focus on customer satisfaction.
2. Expertise.
3. Satisfactory track record.
Risk Of Citichem India IPO
1. There are outstanding actions and litigation proceedings against the Company, Promoter and Directors. Any adverse outcome in such proceedings may have an adverse impact on its reputation, business, financial condition, results of operations and cash flows.
2. There have been instances of delays of certain forms which were required to be filed as per the reporting requirements under the Companies Act, 2013 to RoC.
3. Majority of its revenues are dependent on few customers and the loss of, or a significant reduction in purchases by such customers could adversely affect its financial performance.
4. The company business involves trading of the hazardous, corrosive and flammable industrial chemicals, which require expert handling and storage, as applicable and which entails significant risks and could also result in enhanced obligations. Any accidents may result in loss of life or property and disrupt its operations which may have an adverse effect on the company results of operation, cash flows and financial condition.
5. The Company does not have any registered Trademarks.
6. The Company had negative cash flow in recent fiscals, details of which are given below. Sustained negative cash flow could adversely impact its business, financial condition and results of operations.
7. The Company has not placed orders for transportation vehicles and accessories required by it for which funds are being raised through this Issue. Any delay in placing the orders or supply of these equipment's may result in time and cost overruns and may affect its profitability.
8. The Company's hasn't taken any insurance coverage and the said would not protect it against all material hazards which may result in disruptions of operations/monetary loss on account of stoppage of work.
9. The company does not own its Registered Office and Corporate Office from where the company carry out its business activities. Any dispute in relation to use of the premises would have a material adverse effect on its business and results of operations.
10. An inability to comply with repayment and other covenants in the financing agreements could adversely affect its business, financial condition, and cash flows.
Objectives Citichem India IPO
- For Capital expenditure for acquisition of Property
- For purchasing of Transportation Vehicles and accessories
- For General Corporate Purposes
- For meeting the Issue Expenses.
Company Contact Details
Citichem India Limited
7, Floor-1, Plot-96,
Dharam Jyoti, Kazi Sayed Street, Khand Bazar,
Masjid Station, Mandvi, Mumbai 400003
Phone: +91- 9223278100
Email: cs@citichemindia.com
Website: https://www.citichemindia.com/
Registrar Contact Details
Lead Mangers
Horizon Management Private Limited
Market Maker
Aftertrade Broking